The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated Covid shots, among others.

RGT-075 is an investigational, orally bioavailable, once-daily, small molecule GLP-1R full agonist discovered and developed by Regor for the treatment of metabolic diseases, such as type 2 diabetes ...

A massive cyberincident affecting almost 870,000 Columbia University students, employees, and other individuals occured in May 2025, the university has confirmed. In a new filing with the Office of ...

Beam Therapeutics will present new BEAM-101 data for sickle cell disease at EHA2025, detailing safety and efficacy in 17 patients. Beam Therapeutics Inc. has announced that it will present updated ...

MILAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced ...

Applied Therapeutics, Inc. has announced that it will present full 12-month clinical data, along with new topline data from 18 and 24 months from the INSPIRE Phase 3 trial of its drug govorestat for ...

PHILADELPHIA, PA — iECURE, Inc. will present new clinical data on its experimental gene therapy candidate, ECUR-506, at two international medical meetings in Kyoto, Japan, this September. The therapy ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nucana ( (NCNA)) just unveiled an ...